Dr. Kalinsky on Optical Imaging for HER2+ Breast Cancer

Kevin Kalinsky, MD
Published: Tuesday, Feb 21, 2017



Kevin Kalinsky, MD, assistant professor of Medicine at Columbia University Medical Center, discusses the potential advantages of optical imaging for patients with HER2-positive breast cancer.

Some patients with breast cancer are unable to tolerate MRIs, which makes non-invasive optical imaging beneficial, explains Kalinsky. There is no intravenous injection needed, allowing it to be relatively quick and inexpensive.



Kevin Kalinsky, MD, assistant professor of Medicine at Columbia University Medical Center, discusses the potential advantages of optical imaging for patients with HER2-positive breast cancer.

Some patients with breast cancer are unable to tolerate MRIs, which makes non-invasive optical imaging beneficial, explains Kalinsky. There is no intravenous injection needed, allowing it to be relatively quick and inexpensive.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x